Pro-inflammatory cytokine signaling and immune effector pathways

Pro-inflammatory cytokine signaling and immune effector pathways encompass the integrated biological processes through which the immune system responds to stimuli via the secretion of signaling molecules. These pathways involve a diverse array of cytokines, including Tumor Necrosis Factor (TNF), Interleukins (e.g., IL-1, IL-6, IL-17), and Interferons, which activate specific cell-surface receptors to initiate downstream signaling cascades like the JAK/STAT or NF-κB pathways (Source: Nature Reviews Immunology, 2017). While critical for mounting an effective defense against pathogens and promoting tissue repair, chronic or dysregulated activation of these pathways is a hallmark of numerous inflammatory and autoimmune disorders, such as rheumatoid arthritis and Crohn's disease (Source: NIH/StatPearls, 2023). Therapeutic strategies often focus on neutralizing specific cytokines or inhibiting their associated receptors and intracellular transducers to restore immune homeostasis. Because this term describes a broad functional category of biological activity rather than a single molecular entity, it does not constitute a discrete therapeutic target in the traditional sense.

Other names

Inflammatory signaling pathwaysCytokine-mediated immune responsePro-inflammatory cascadeImmune effector mechanisms

Modulation of immune responses through the inhibition of specific cytokines, cytokine receptors, or intracellular signaling transducers such as Janus kinases (JAKs) and MAP kinases.